Our promising pipeline of
innovative product candidates are
designed to target and help resolve
serious unmet medical needs
Pushing the boundaries of breakthrough therapies
Summit is initiating development activities for SMT112 and will do so first in NSCLC indications.
Focused on innovations leveraging deep leadership expertise in discovery and advancement of novel platforms.